The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism

Author： Fox John Lowe Stacey Conklin Rebecca Nemeth Edward

Publisher： Humana Press, Inc

ISSN： 0969-711X

Source： Endocrine Journal, Vol.10, Iss.2, 1999-04, pp. : 97-103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calcimimetic Compounds: a Direct Approach to Controlling Plasma Levels of Parathyroid Hormone in Hyperparathyroidism

By Nemeth E.F. Fox J.

Trends in Endocrinology and Metabolism, Vol. 10, Iss. 2, 1999-03 ,pp. : 66-71

Elsevier

Access to resources Recommend Favorite

Spotlight on Paricalcitol in Secondary Hyperparathyroidism

By Robinson Dean M. Scott Lesley J.

Treatments in Endocrinology, Vol. 4, Iss. 3, 2005-01 ,pp. : 185-186

Adis International

Access to resources Recommend Favorite

Hyperparathyroidism Secondary to Hyperaldosteronism

By Fortina Felice

High Blood Pressure & Cardiovascular Prevention, Vol. 17, Iss. 1, 2010-03 ,pp. : 27-30

Adis International

Access to resources Recommend Favorite

Decreased expression of calcium receptor in parathyroid tissue in patients with hyperparathyroidism secondary to chronic renal failure

By Martín-Salvago María Villar-Rodríguez José Palma-Álvarez Alfonso Beato-Moreno Antonio Galera-Davidson Hugo

Endocrine Pathology, Vol. 14, Iss. 1, 2003-03 ,pp. : 61-70

Humana Press, Inc

Access to resources Recommend Favorite

Coeliac disease in subjects with secondary hyperparathyroidism

By Jorde R. Saleh F. Sundsfjord J. Haug E. Skogen B.

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 2, 2005-02 ,pp. : 178-182

Informa Healthcare

Access to resources Recommend Favorite